The California Institute of Technology ranks as one of the top universities in the world when it comes to receiving patents. But more of those inventions should successfully be making it to market, at least according to the investment thesis of Freeflow, a new pre-seed and seed stage venture firm that exclusively backs Caltech startups focused on human and planetary health.
"The people there are amazing scientists who are not afraid to tackle the hard problems," said Freeflow founder and managing partner David Fleck, who was an early Google employee who has spent the last 20 years tackling big data. "But as I started to spend more time there I realized the ecosystem was somewhat underdeveloped. They needed investors that could help them with capital and help them develop a company."
David Fleck, who started Freeflow after he sold his online commenting service, Disqus, for a reported $90 million in 2017, hopes to broaden the perception of Los Angeles from a consumer tech hub to a place with the sorts of deep tech companies more commonly associated with where he spent most of his career, Silicon Valley.
- Los Angeles Mayor Eric Garcetti on Startups and technology - dot.LA ›
- A New VC Hopes to Unlock the Potential in Caltech's Patents - dot.LA ›
- A New VC Hopes to Unlock the Potential in Caltech's Patents - dot.LA ›
- David Fleck Of FreeFlow Invests In Caltech Startups - dot.LA ›
- David Fleck Of FreeFlow Invests In Caltech Startups - dot.LA ›